Gentamicin therapy in renal failure: a nomogram for dosage.
about
Aminoglycoside Prescribing and Surveillance in Cystic FibrosisClinical and pharmacokinetic characteristics of aminoglycoside nephrotoxicity in 201 critically ill patientsEstimation of pharmacokinetic parameters based on the patient-adjusted population data.Screening for aminoglycoside auditory toxicity in the old.Comparison of Sawchuk-Zaske and Bayesian forecasting for aminoglycosides in seriously ill patientsEvaluation of a microcomputer program (OPT) for parameter optimisation in clinical pharmacokinetics: gentamicin and tobramycin.Comparison of methods for estimating gentamicin clearance and retrospective analysis of changes in clearance with emphasis on patients with normal renal functionProspective comparative study of variable dosage and variable frequency regimens for administration of gentamicin.Increased aminoglycoside dosage requirements in hematologic malignancy.Pharmacokinetics of tobramycin and gentamicin in abusers of intravenous drugs.Pharmacokinetics of gentamicin and kanamycin during hemodialysis.Gentamicin pharmacokinetics in 1,640 patients: method for control of serum concentrations.Correlation of aminoglycoside dosages with serum concentrations during therapy of serious gram-negative bacillary diseaseMy child is unique; the pharmacokinetics are universal.Once-daily aminoglycoside administration: new strategies for an old drug.Clinical pharmacokinetics, toxicity and cost effectiveness analysis of aminoglycosides and aminoglycoside dosing services.Predicted and measured aminoglycoside pharmacokinetic parameters in critically ill patients.Lack of evidence for interaction between tobramycin and shock in their effect on renal function.Prescribing aids for gentamicin.Netilmicin treatment of complicated urinary tract infection in patients with renal function impairment.Intravenous streptomycin use in a patient infected with high-level, gentamicin-resistant Streptococcus faecalis.Inactivation of gentamicin by penicillins in patients with renal failure.Pharmacoeconomic evaluation of once-daily aminoglycoside treatment.Simplified assay for gentamicin in the presence of other antibiotics.Radioimmunoassay for measurement of gentamicin in blood.A model for the prospective identification of the prenephrotoxic state during gentamicin therapy.Editorials: Rational drug therapy in patients with renal disease.Dosage schedule of gentamicin for chronic renal insufficiency in children.Cefotaxime is more effective than is ampicillin-tobramycin in cirrhotics with severe infections.Aminoglycoside pharmacokinetics on a microcomputer.Doses of tobramycin for patients with compromised renal function.Effect of furosemide on aminoglycoside-induced nephrotoxicity and auditory toxicity in humans.Performance of two predictive methods for calculation of the key pharmacokinetic parameters for gentamicin dosage individualization.Gentamicin in clinical practice.Iatrogenic factors in acute renal failure: can vigilance equal avoidance?Reappraisal of guidelines for pharmacokinetic monitoring of aminoglycosides.Pharmacokinetic analysis of gentamicin dosage regimens recommended for renal impairment.A microcomputer program for tobramycin consult services, based on the two-compartment pharmacokinetic model.A practical alternative to conventional aminoglycoside dosing methods.Clinical Pharmacy: Case Studies
P2860
Q22306318-FFE34DE1-272D-4822-8F62-9627EB47003AQ28367851-E49A75FB-1CCA-4BB9-8652-654D937ED9D3Q31082856-CC4D9C89-EE7D-412F-B8E0-94E291FE1093Q34357707-28E05708-70D1-48C9-9332-0612F7BB8BE9Q34397816-48A10EF5-2858-4AD7-939E-9BA0110E02B0Q34417050-F9EEC118-C084-4509-B94B-FB6328121EDEQ34620939-3ACB045C-2268-4A6E-9644-1B9811742EE7Q34948994-93A210F9-AB12-4CEC-8F0D-81538E39EF4FQ35253342-F92973D5-1F06-4CA2-8953-EB043FD1D286Q35570201-D258D7C0-8D91-49D5-B33F-E5720B4C8E36Q35660758-B6898BBA-CBBC-4992-86BA-FE61F632A661Q35674282-0FFA4E41-791C-43D9-97CF-D51954A39F47Q36483889-0F510FD3-6129-429C-B7B3-0F46D618A713Q37973872-5B91EA9B-FF46-416A-BC9D-7AD52EC3DE86Q38239743-6840DE32-83EA-47FE-BE4B-BAB09AAB52F9Q39598341-998FA015-55DA-4596-9E2C-A32F74586B99Q39829144-01F068F2-6038-4627-8B78-365753431F3EQ39833789-FBF4D096-17E4-48B1-A02A-06536138E41BQ40028168-96C881E3-850B-4443-8024-2196EA7BF867Q40621050-550E0F67-8500-420A-BD9A-864443074D0DQ40824627-9BB4063E-2790-4488-958F-7E50A7B4DCF4Q40946710-33AB1C31-9A7F-41E4-A157-2BD10B5A9CEFQ40949900-54950850-4F24-4B92-B478-122F786A7E2EQ41029262-D7C7327B-8C09-4F65-BA29-7A9862EC51F9Q41029287-1E86214C-D17B-43BD-B336-591141E01553Q41847098-E887173C-4133-4F73-B8F9-38575D0A3DFFQ42067494-E49B4D03-E704-4EE5-A765-C6AF009A8A60Q42130440-8944A1C0-D5CC-4899-8F13-C14B844169E5Q42225157-2969148A-FFEE-4966-8FB5-0219426108ADQ42668043-290F4609-84E2-450C-8D9F-DE2AC692C2F7Q42778155-56E54D73-BFFA-4570-8075-6EE5C1D36278Q42928339-EDAAB857-3BEA-4B1E-988C-C6516AC5B6AAQ43988788-58862B25-A8E3-4B98-AC41-8BEFEB96FA87Q44683837-94D5BB96-C9CB-42F0-90AD-B413260BD9E1Q44739046-DD9BE764-B406-4F14-A2C0-FE967200B869Q45006893-67B881D8-665D-4B27-AAF5-48634275CDD1Q45823535-FE89C58D-FE5C-48DA-8FCC-937F294DE863Q48662614-669172FC-94E4-4307-9BC7-6FE56A6DC0C8Q52388435-B5FFB8FA-4350-47FE-87EF-1354D3A85D58Q56336433-F2B27307-99CC-42E9-AB57-45401D0FBFD0
P2860
Gentamicin therapy in renal failure: a nomogram for dosage.
description
1972 nî lūn-bûn
@nan
1972年の論文
@ja
1972年学术文章
@wuu
1972年学术文章
@zh-cn
1972年学术文章
@zh-hans
1972年学术文章
@zh-my
1972年学术文章
@zh-sg
1972年學術文章
@yue
1972年學術文章
@zh
1972年學術文章
@zh-hant
name
Gentamicin therapy in renal failure: a nomogram for dosage.
@en
Gentamicin therapy in renal failure: a nomogram for dosage.
@nl
type
label
Gentamicin therapy in renal failure: a nomogram for dosage.
@en
Gentamicin therapy in renal failure: a nomogram for dosage.
@nl
prefLabel
Gentamicin therapy in renal failure: a nomogram for dosage.
@en
Gentamicin therapy in renal failure: a nomogram for dosage.
@nl
P2093
P1476
Gentamicin therapy in renal failure: a nomogram for dosage.
@en
P2093
P304
P356
10.7326/0003-4819-76-5-773
P407
P577
1972-05-01T00:00:00Z